Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine versus chlorambucil in untreated symptomatic B-cell chronic lymphocytic leukemia
ISRCTN03739647Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) comparing Bendamustine with Chlorambucil (2 arms). Primary endpoints: Overall response rate and Progression-free survival. Started Nov 2002; status: completed.
02
Drugs
bendamustinechlorambucil
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on ISRCTN03739647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03739647.